Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
-0.35 (-0.70%)
5:25:30 PM EDT: $49.70 -0.06 (-0.12%)

Myovant Sciences And Pfizer Receive U.S. FDA Approval Of Myfembree®

Published: 08/06/2022 01:00 GMT
Pfizer Inc. (PFE) - Myovant Sciences and Pfizer Receive U.S. FDA Approval of Myfembree®, a Once-daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.
Myovant Sciences Ltd- Myovant and Pfizer Will Continue to Jointly Commercialize Myfembree, With Product Available Immediately.